A detailed history of Kb Financial Partners, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Kb Financial Partners, LLC holds 348 shares of BMRN stock, worth $23,187. This represents 0.01% of its overall portfolio holdings.

Number of Shares
348
Previous 230 51.3%
Holding current value
$23,187
Previous $20,000 55.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$85.07 - $94.48 $10,038 - $11,148
118 Added 51.3%
348 $31,000
Q4 2022

Feb 17, 2023

BUY
$80.93 - $108.63 $18,613 - $24,984
230 New
230 $24,000
Q2 2021

Aug 17, 2021

SELL
$75.51 - $84.79 $157,136 - $176,447
-2,081 Closed
0 $0
Q1 2021

Jun 08, 2021

BUY
$74.73 - $90.69 $155,513 - $188,725
2,081 New
2,081 $157,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.